The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials

BACKGROUND: Eye tracking (ET) is a powerful methodology for studying attentional processes through quantification of eye movements. The precision, usability, and cost-effectiveness of ET render it a promising platform for developing biomarkers for use in clinical trials for autism spectrum disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Shic, Frederick, Naples, Adam J., Barney, Erin C., Chang, Shou An, Li, Beibin, McAllister, Takumi, Kim, Minah, Dommer, Kelsey J., Hasselmo, Simone, Atyabi, Adham, Wang, Quan, Helleman, Gerhard, Levin, April R., Seow, Helen, Bernier, Raphael, Charwaska, Katarzyna, Dawson, Geraldine, Dziura, James, Faja, Susan, Jeste, Shafali Spurling, Johnson, Scott P., Murias, Michael, Nelson, Charles A., Sabatos-DeVito, Maura, Senturk, Damla, Sugar, Catherine A., Webb, Sara J., McPartland, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124777/
https://www.ncbi.nlm.nih.gov/pubmed/35313957
http://dx.doi.org/10.1186/s13229-021-00482-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124777/
https://www.ncbi.nlm.nih.gov/pubmed/35313957
http://dx.doi.org/10.1186/s13229-021-00482-2

Ejemplares similares